| Spirig HealthCare AG - Ruxolitinib Spirig HC 10 mg, Tabletten |
| 70513 | | 02 | | Ruxolitinib Spirig HC 10 mg | | Tabletten | | L01EJ01 | | Ruxolitinib | | 15.10.2026 | | |
|
| Composition |
| ruxolitinibum 10 mg ut ruxolitinibum dihydricum, cellulosum microcristallinum, lactosum monohydricum 150.4 mg, hydroxypropylcellulosum, carboxymethylamylum natricum A corresp. natrium max. 0.42 mg, silica colloidalis anhydrica, magnesii stearas, pro compresso. |
| Packungsbestandteile |
| Comprimés | | | | Principe actif | Concentr. |
|---|
| Ruxolitinibum | 10 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Carboxymethylamylum Natricum A | | | Cellulosum Microcristallinum | | | Hydroxypropylcellulosum | | | Lactose Monohydrate | 150.4 mg | | Magnesii Stearas | | | Pro Compresso | | | Silica Colloidalis Anhydrica | |
|
|
| numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 56 | | | A | | Oui |
|
